ArticleACS omega2026
Synergistic EMI Shielding Efficiency of Biodegradable PLA/PBS-Based Composites Reinforced with Carbon Fibers and ZnO Nanoparticles.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The escalating electromagnetic pollution from modern electronics, combined with the global plastic waste crisis, demands the development of high-performance EMI shielding materials based on sustainable and biodegradable polymers. Biodegradable polyesters such as polylactic acid (PLA) and polybutylene succinate (PBS) offer a compelling solution owing to their renewable origin, low carbon footprint, and susceptibility to enzymatic degradation by proteases, lipases, and esterases under composting conditions, which enable responsible end-of-life disposal and support circular economy principles. In this context, this study focuses on the development of biodegradable PLA/PBS-based composites with exceptional electromagnetic interference (EMI) shielding effectiveness through the synergistic combination of carbon fibers (CF) and ZnO nanoparticles. A fixed CF content of 20 wt % was employed to establish a conductive backbone, while ZnO nanoparticles were incorporated at 1, 3, 5, and 7 wt % to enhance dielectric loss and absorption-based shielding. EMI shielding measurements in the X-band revealed a dramatic improvement in total shielding effectiveness (SET), increasing from 1.7 dB for the PLA/PBS matrix to 30.7 dB with CF reinforcement and reaching 70, 59, 73, and 85 dB for composites containing 1, 3, 5, and 7 wt % ZnO, respectively. The composite containing 1 wt % ZnO exhibited the most efficient EMI shielding response relative to filler content, achieving a high SET of ∼70 dB with minimal nanoparticle loading. This superior performance was attributed to the uniform dispersion of ZnO nanoparticles, which maximized interfacial polarization, dielectric loss, and multiple internal scattering within the carbon fiber-supported network. Structural, rheological, thermal, and mechanical analyses consistently showed that increasing ZnO content beyond 1 wt % led to nanoparticle agglomeration, network disruption, reduced melt elasticity, and mechanical embrittlement, despite further increases in absolute SET at higher loadings. EMI shielding in all composites was dominated by absorption (SEA > 80%), making them particularly suitable for practical EMI mitigation applications. These findings demonstrate that optimized ZnO dispersion at low loading is a key factor in achieving efficient, absorption-dominant EMI shielding in biodegradable polymer composites, offering a sustainable and environmentally responsible alternative to conventional metal-based and petroleum-derived polymer shielding materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.